Madrigal Pharmaceuticals Inc (MDGL)
Madrigal Receives Positive CHMP Opinion for Resmetirom(Rezdiffra™) for the Treatment of MASH with Moderate to Advanced Liver Fibrosis
Madrigal Receives Positive CHMP Opinion for Resmetirom(Rezdiffra™) for the Treatment of MASH with Moderate to Advanced Liver Fibrosis
There are no comments here yet...